What is the address of DR. OLIVIER PRADIER, MEDECIN BIOLOGISTE?

The registered office of DR. OLIVIER PRADIER, MEDECIN BIOLOGISTE is located at Rue de la Bachée 51, 1380 Lasne.

Is DR. OLIVIER PRADIER, MEDECIN BIOLOGISTE still active?

Yes. According to the CBE (30 September 2026) DR. OLIVIER PRADIER, MEDECIN BIOLOGISTE is active, legal situation “Normale toestand”, started on 17 January 2018.

Is DR. OLIVIER PRADIER, MEDECIN BIOLOGISTE registered on Peppol?

No, DR. OLIVIER PRADIER, MEDECIN BIOLOGISTE is currently not registered on the Peppol network.

What is the enterprise number of DR. OLIVIER PRADIER, MEDECIN BIOLOGISTE?

The enterprise number of DR. OLIVIER PRADIER, MEDECIN BIOLOGISTE is BE0688558953.

When was DR. OLIVIER PRADIER, MEDECIN BIOLOGISTE founded?

DR. OLIVIER PRADIER, MEDECIN BIOLOGISTE was founded on 17 January 2018.

Who are the directors of DR. OLIVIER PRADIER, MEDECIN BIOLOGISTE?

According to the 2025 annual accounts, the directors of DR. OLIVIER PRADIER, MEDECIN BIOLOGISTE are: Olivier Pradier.

Is DR. OLIVIER PRADIER, MEDECIN BIOLOGISTE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 17 January 2018; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DR. OLIVIER PRADIER, MEDECIN BIOLOGISTE make in 2025?

DR. OLIVIER PRADIER, MEDECIN BIOLOGISTE posted a profit after taxes of € 85,861 in financial year 2025.

What is the revenue of DR. OLIVIER PRADIER, MEDECIN BIOLOGISTE?

As a small company, DR. OLIVIER PRADIER, MEDECIN BIOLOGISTE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 129,522.

DR. OLIVIER PRADIER, MEDECIN BIOLOGISTE (Private Limited)

Dossier DR. OLIVIER PRADIER, MEDECIN BIOLOGISTE, printed on 30 September 2026 from databakkes.be/en/0688558953/dr-olivier-pradier-medecin-biologiste. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2025

DR. OLIVIER PRADIER, MEDECIN BIOLOGISTE from Lasne, company number BE0688558953, closed financial year 2025 with a result of € 85,861 after tax. For that financial year DR. OLIVIER PRADIER, MEDECIN BIOLOGISTE recorded a gross margin of € 129,522 and equity of € 694,530. Compared with financial year 2024, the result moved from € 104,157 to € 85,861. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 20, 2026.

What it is worth Healthy

€ 694,530

▼ 6% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 85,861

▼ 18% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 17,864

▲ 1% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 129,070 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Vehicles and equipment

€ 9,237

▲ 36% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

€ 16,114

▼ 35% vs 2024

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 4,707

▼ 10% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 42,208

▼ 75% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 407,780 Gross margin 2022: € 407,780 First fiscal year in the series	€ 566,896 Gross margin 2023: € 566,896 ▲ 39% vs 2022 (€ 407,780) Favourable step	€ 169,027 Gross margin 2024: € 169,027 ▼ 70% vs 2023 (€ 566,896) Unfavourable step	€ 129,522 Gross margin 2025: € 129,522 ▼ 23% vs 2024 (€ 169,027) Unfavourable step	▼ 23%
Profit after taxes	€ 285,464 Profit after taxes 2022: € 285,464 First fiscal year in the series	€ 370,831 Profit after taxes 2023: € 370,831 ▲ 30% vs 2022 (€ 285,464) Favourable step	€ 104,157 Profit after taxes 2024: € 104,157 ▼ 72% vs 2023 (€ 370,831) Unfavourable step	€ 85,861 Profit after taxes 2025: € 85,861 ▼ 18% vs 2024 (€ 104,157) Unfavourable step	▼ 18%
Equity	€ 494,272 Equity 2022: € 494,272 First fiscal year in the series	€ 665,656 Equity 2023: € 665,656 ▲ 35% vs 2022 (€ 494,272) Favourable step	€ 737,739 Equity 2024: € 737,739 ▲ 11% vs 2023 (€ 665,656) Favourable step	€ 694,530 Equity 2025: € 694,530 ▼ 6% vs 2024 (€ 737,739) Unfavourable step	▼ 6%
Total debts	€ 651,459 Total debts 2022: € 651,459 First fiscal year in the series	€ 501,821 Total debts 2023: € 501,821 ▼ 23% vs 2022 (€ 651,459) Favourable step	€ 199,318 Total debts 2024: € 199,318 ▼ 60% vs 2023 (€ 501,821) Favourable step	€ 63,028 Total debts 2025: € 63,028 ▼ 68% vs 2024 (€ 199,318) Favourable step	▼ 68%
Cash	€ 305,378 Cash 2022: € 305,378 First fiscal year in the series	€ 79,412 Cash 2023: € 79,412 ▼ 74% vs 2022 (€ 305,378) Unfavourable step	€ 17,665 Cash 2024: € 17,665 ▼ 78% vs 2023 (€ 79,412) Unfavourable step	€ 17,864 Cash 2025: € 17,864 ▲ 1% vs 2024 (€ 17,665) Favourable step	▲ 1%
Land & buildings	€ 508,222 Land & buildings 2022: € 508,222 First fiscal year in the series	€ 491,558 Land & buildings 2023: € 491,558 ▼ 3% vs 2022 (€ 508,222) Unchanged	€ 474,893 Land & buildings 2024: € 474,893 ▼ 3% vs 2023 (€ 491,558) Unchanged	€ 458,229 Land & buildings 2025: € 458,229 ▼ 4% vs 2024 (€ 474,893) Unchanged	▼ 4%
Retained profit	€ 464,272 Retained profit 2022: € 464,272 First fiscal year in the series	€ 635,656 Retained profit 2023: € 635,656 ▲ 37% vs 2022 (€ 464,272) Favourable step	€ 707,739 Retained profit 2024: € 707,739 ▲ 11% vs 2023 (€ 635,656) Favourable step	€ 664,530 Retained profit 2025: € 664,530 ▼ 6% vs 2024 (€ 707,739) Unfavourable step	▼ 6%
Dividend	€ 352,941 Dividend 2022: € 352,941 First fiscal year in the series	€ 199,447 Dividend 2023: € 199,447 ▼ 43% vs 2022 (€ 352,941) Unchanged	€ 32,074 Dividend 2024: € 32,074 ▼ 84% vs 2023 (€ 199,447) Unchanged	€ 129,070 Dividend 2025: € 129,070 ▲ € 96,996 vs 2024 (€ 32,074) Unchanged	▲ € 96,996
Bank debt	€ 170,937 Bank debt 2022: € 170,937 First fiscal year in the series	€ 98,318 Bank debt 2023: € 98,318 ▼ 42% vs 2022 (€ 170,937) Favourable step	€ 24,741 Bank debt 2024: € 24,741 ▼ 75% vs 2023 (€ 98,318) Favourable step	€ 16,114 Bank debt 2025: € 16,114 ▼ 35% vs 2024 (€ 24,741) Favourable step	▼ 35%
Balance sheet total	€ 1,145,731 Balance sheet total 2022: € 1,145,731 First fiscal year in the series	€ 1,167,476 Balance sheet total 2023: € 1,167,476 ▲ 2% vs 2022 (€ 1,145,731) Unchanged	€ 937,057 Balance sheet total 2024: € 937,057 ▼ 20% vs 2023 (€ 1,167,476) Unchanged	€ 757,558 Balance sheet total 2025: € 757,558 ▼ 19% vs 2024 (€ 937,057) Unchanged	▼ 19%

Key figures of DR. OLIVIER PRADIER, MEDECIN BIOLOGISTE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DR. OLIVIER PRADIER, MEDECIN BIOLOGISTE?

What happened at DR. OLIVIER PRADIER, MEDECIN BIOLOGISTE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 20, 2026 New annual accounts for financial year 2025: profit of € 85,861 (▼ 18% vs 2024). filed late Source: NBB ↗
Jan 17, 2018 New establishment in Lasne. KBO
Jan 17, 2018 Start of the company according to the CBE. KBO

In short

From € 285,464 profit in 2022 to € 85,861 profit in 2025.

Paid € 360,064 in corporate taxes since 2022.

Best year ever: 2023, with € 370,831 profit.

Paid out € 713,532 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at DR. OLIVIER PRADIER, MEDECIN BIOLOGISTE? We notify you, reason included.

Follow DR. OLIVIER PRADIER, MEDECIN BIOLOGISTE

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Olivier Pradier

DR. OLIVIER PRADIER, MEDECIN BIOLOGISTE

Behind DR. OLIVIER PRADIER, MEDECIN BIOLOGISTE is Olivier Pradier.

See the full network in the app

Directors

According to the 2025 annual accounts

Olivier Pradier

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Rue de la Bachée 51

1380 Lasne

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0688.558.953
VAT number: BE 0688.558.953
Registered office: Rue de la Bachée 51, 1380 Lasne
Names & denominations: DR. OLIVIER PRADIER, MEDECIN BIOLOGISTE
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 17 January 2018
Peppol: Not registered

View on CBE Public ↗ Annual accounts (NBB) ↗